Global Generic Injectables Market to Reach $227.5 Billion by 2030
The global market for Generic Injectables estimated at US$112.6 Billion in the year 2023, is expected to reach US$227.5 Billion by 2030, growing at a CAGR of 10.6% over the period 2023-2030. Large Molecule Injectables, one of the segments analyzed in the report, is expected to record 11.4% CAGR and reach US$156.9 Billion by the end of the analysis period. Growth in the Small Molecule Injectables segment is estimated at 8.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $30 Billion, While China is Forecast to Grow at 14.3% CAGR
The Generic Injectables market in the U.S. is estimated at US$30 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$51.5 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 8.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook